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Abstract
Adiponectin is a mammalian hormone that exerts anti-diabetic, anti-cancer and cardioprotective effects through interaction
with its major ubiquitously expressed plasma membrane localized receptors, AdipoR1 and AdipoR2. Here, we report a
Saccharomyces cerevisiae based method for investigating agonist-AdipoR interactions that is amenable for high-throughput
scale-up and can be used to study both AdipoRs separately. Agonist-AdipoR1 interactions are detected using a split firefly
luciferase assay based on reconstitution of firefly luciferase (Luc) activity due to juxtaposition of its N- and C-terminal
fragments, NLuc and CLuc, by ligand induced interaction of the chimeric proteins CLuc-AdipoR1 and APPL1-NLuc (adaptor
protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 1-NLuc) in a S.
cerevisiae strain lacking the yeast homolog of AdipoRs (Izh2p). The assay monitors the earliest known step in the
adiponectin-AdipoR anti-diabetic signaling cascade. We demonstrate that reconstituted Luc activity can be detected in
colonies or cells using a CCD camera and quantified in cell suspensions using a microplate reader. AdipoR1-APPL1
interaction occurs in absence of ligand but can be stimulated specifically by agonists such as adiponectin and the tobacco
protein osmotin that was shown to have AdipoR-dependent adiponectin-like biological activity in mammalian cells. To
further validate this assay, we have modeled the three dimensional structures of receptor-ligand complexes of membrane-
embedded AdipoR1 with cyclic peptides derived from osmotin or osmotin-like plant proteins. We demonstrate that the
calculated AdipoR1-peptide binding energies correlate with the peptides’ ability to behave as AdipoR1 agonists in the split
luciferase assay. Further, we demonstrate agonist-AdipoR dependent activation of protein kinase A (PKA) signaling and AMP
activated protein kinase (AMPK) phosphorylation in S. cerevisiae, which are homologous to important mammalian
adiponectin-AdipoR1 signaling pathways. This system should facilitate the development of therapeutic inventions targeting
adiponectin and/or AdipoR physiology.
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Introduction
Adiponectin is a protein hormone secreted by adipose tissue in
mammals and it plays crucial roles in the regulation of glucose and
lipid metabolism, inflammation and oxidative stress [1,2,3,4].
Missense mutations in the adiponectin gene are associated with the
incidence of type 2 diabetes [5,6]. Reduced serum concentrations
of adiponectin correlate with obesity, type 2 diabetes, cardiovas-
cular risk, as well as increased risk of several types of cancer
[7,8,9]. Administration of recombinant adiponectin or genetic
overexpression of adiponectin in rodent models has therapeutic
effects in diabetes, ischemic cardiac injury and in colon cancer
[10,11,12,13,14,15,16]. These findings triggered the great atten-
tion adiponectin receives today and support the development of
therapeutic agents based on adiponectin replacement.
Adiponectin is a 30 kDa protein that consists of a N-terminal
collagen domain and a C-terminal globular C1q domain [3]. It is a
highly abundant serum protein. In serum, adiponectin is
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glycosylated and exists as a trimer, hexamer and higher order
oligomers. The globular C1q domain can be released by
proteolysis and is biologically active, but it is not found in
significant amounts in serum. Several in vitro and in vivo studies
have shown that two proteins, AdipoR1 and AdipoR2, serve as the
major receptors for adiponectin [11,17]. AdipoRs and G-protein
coupled receptors (GPCRs) share a 7-transmembrane pass
topology but are functionally distinct. Also, as members of the
PAQR (Progestin and AdipoQ Receptor) family, AdipoRs have an
cytosolic N-terminus and external C-terminus, which is the
opposite orientation of classical GPCRs [18].
The signaling pathways activated by adiponectin depend on (a)
the molecular form (glycosylation status and degree of oligomer-
ization) of adiponectin, since the different forms show selectivity
for the two AdipoRs, (b) the relative abundance of the two
AdipoRs, since the receptors show selectivity for downstream
signaling, and (c) the target tissue [17,19,20,21]. For example,
AdipoR1 acts as a high affinity receptor for globular adiponectin
and has a lower affinity for full length adiponectin, while AdipoR2
possesses medium affinity for these adiponectin variants [21]. In
skeletal muscle cells, the anti-diabetic effect of adiponectin is
mediated by stimulation of glucose oxidation via the AMP
activated protein kinase (AMPK) pathway and by increase of
fatty acid oxidation via the AMPK and peroxisome proliferator-
activated receptor a (PPARa) pathways [3,20]. In the liver, the
anti-diabetic action of adiponectin is linked to increased gluco-
neogenesis via AMPK activation, whereas stimulation of fatty acid
oxidation, decrease of inflammation and increased insulin
sensitivity are achieved via the PPARa pathway [17]. In vascular
endothelial cells adiponectin has an anti-inflammatory effect due
to enhanced nitric oxide production, suppression of oxidative
stress and suppression of inflammatory signaling [22]. These anti-
inflammatory effects of adiponectin in the vascular endothelium
have been explained by AMPK activation and a cyclic AMP-
protein kinase A (cAMP-PKA) pathway. In cardiomyocytes, the
protective effects of adiponectin are mediated by AMPK and
cyclo-oxygenase 2 signaling [22]. AdipoR1 exerts the major effect
in mediating the anti-diabetic action of adiponectin in skeletal
muscle whereas both AdipoRs have major roles in its anti-diabetic
actions in the liver [17,20].
These studies suggest that there is considerable value in the
identification of AdipoR agonists as therapeutic agents. It is also
evident that identification of signaling pathways specifically
activated by an interaction between an agonist and one of the
AdipoRs would provide valuable information for the design of
therapeutic agents. We reasoned that a system designed to perform
such studies in the budding yeast Saccharomyces cerevisiae would
combine several advantages as detailed below.
First, reactions and regulatory steps of glucose and lipid
metabolism are very similar in yeast and mammalian cells [23].
Energy metabolism in S. cerevisiae is connected to glucose and lipid
metabolism via the same pathways that exist in mammalian cells.
Importantly, AMPKs of mammals and S. cerevisiae have similar
subunit structure [24,25]. S. cerevisiae and mammalian AMPKs can
be cross-activated by their respective upstream kinases due to
sequence similarity between the corresponding subunits. S. cerevi-
siae and mammalian AMPKs play similar roles in balancing energy
demand with energy supply from carbohydrate and lipid
metabolism (Figure 1).
Second, although four S. cerevisiae proteins Izh1p, Izh2p, Izh3p,
and Izh4p share deduced sequence similarity with mammalian
AdipoRs, adiponectin is unable to stimulate intracellular signaling
that leads to repression of ferroxidase (FET3), a gene involved in
metal ion homeostasis in yeast, unless AdipoR1 or AdipoR2 are
expressed [26]. These results demonstrate that it is possible to
examine signaling from AdipoR1 and AdipoR2 separately in
yeast.
Third, activation of PKA and regulation of gene expression by
AMPK due to adiponectin-AdipoR interaction contribute to the
beneficial effects of adiponectin in mammalian systems [3,22,24].
Signaling from Izh2p and AdipoRs has also been shown to activate
the PKA pathway and affect AMPK-dependent gene expression in
S. cerevisiae (Figure 1). Izh2p and AdipoRs negatively regulate
expression of genes involved in metal ion homeostasis through
both PKA and AMPK in S. cerevisiae, via a CCCTC promoter
element [26,27]. It should be noted activation of PKA has an
opposite effect on the cellular reactive oxygen species (ROS)
content in mammalian and yeast systems. Activation of the
AdipoR-PKA pathway decreases cellular content of ROS in
mammalian vascular endothelial cells [22]. On the other hand,
activation of the IZH2-PKA pathway signaling has been shown to
suppress transcription from the CCCCT stress-responsive pro-
moter element (STRE) that is found on some oxidative stress
inducible genes, which increases the cellular content of ROS in S.
cerevisiae [27,28,29].
However, adiponectin-AdipoR dependent activation of AMPK
via increased phosphorylation of the S. cerevisiae AMPKa subunit,
Snf1p, has not yet been described. Since this activating
phosphorylation plays a key role in the anti-diabetic actions of
adiponectin in skeletal muscle and liver, and in the cardioprotec-
tive actions of adiponectin [3,19,22], evidence for a central
element in yeast adiponectin-AdipoR signaling is missing. Hence,
we set out to establish S. cerevisiae systems to (a) accurately report
agonist-AdipoR interactions and (b) report the agonist-AdipoR
dependent activation of signaling pathways similar to those known
to be important for controlling diabetes or cardiovascular function
in mammals. Here we report a split firefly luciferase based assay
for investigating ligand-AdipoR1 interactions. We further show
that activation of yeast AMPK by phosphorylation of its a subunit,
Snf1p, can be observed in response to agonist-AdipoR1 or agonist-
AdipoR2 interaction in S. cerevisiae and demonstrate agonist-
AdipoR dependent suppression of oxidative stress signaling via
activation of the PKA pathway in S. cerevisiae. The split luciferase
assays can be adapted easily for multiwell arrays suitable for high-
throughput platforms using automated replica plating and
mechanized washing. Hence our S. cerevisiae based system promises
to be an effective tool for the identification of novel pharmaceu-
tically active AdipoR agonists. It will also facilitate structure-
function studies of AdipoRs and analyses of the influence of ligand
structure on ligand-AdipoR interactions, which could serve as
basis for intelligent agonist synthesis.
Materials and Methods
Strains and Growth Media
S. cerevisiae strains were derivatives of BWG1-7a MATa ade1-100
ura3-52 leu2-3,112 his4-519 GAL+ [30] or BY4741 (MATa his3D1
leu2D0 met5D0 ura3D0) (from Dr. D. Ramotar, Universite de
Montreal). Yeast cells were grown at 30uC in either YPD (1%
yeast extract, 2% peptone, 2% dextrose) or selective synthetic
complete medium [0.67% yeast nitrogen base without amino
acids, 2% dextrose, pH 5.7, supplemented with appropriate
dropout mix (Clontech, Mountain View, CA, USA)]. For control
of gene expression under the GAL promoter, dextrose was
substituted by raffinose and/or galactose to a final concentration
of 2%. Yeast cells were transformed by the lithium acetate method
[31]. Targeted insertion or deletion mutations of IZH2, SNF1, and
Assay Method for Ligand-Mediated AdipoR Signaling
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SIP3 were made using the KanMX4 gene as described [32] and
confirmed by PCR.
Construction of Plasmids
Construction of the plasmid pSTRE-lacZ (LEU2) has been
described earlier [29]. The entire coding regions of the human
adiponectin receptors AdipoR1 and AdipoR2 and Adaptor
protein containing Pleckstrin homology domain, Phosphotyrosine
binding domain and Leucine zipper motif 1 (APPL1) were
obtained by RT-PCR from total RNA isolated from MCF-7
breast cancer cells. The sequences of the primers used in the
constructions described below are shown in Table S1. The PCR
products obtained using primer pairs AdipoR1-F-Spe1/AdipoR1-
R-Cla1 and AdipoR2-F-Spe1/AdipoR2-R-Cla1 were inserted
into an intermediate vector by TA cloning, then excised with
SpeI and ClaI and inserted into the corresponding sites of p426-
GPD for construction of the plasmids p426-GPD-AdipoR1 and
p426-GPD-AdipoR2. APPL1 coding sequence was amplified
using primers APPL1-F-KpnI-SpeI and APPL1-R-SalI-1. The
PCR product was cut with KpnI and SalI and inserted between
Figure 1. Summary of AdipoR-mediated signaling pathways in mammalian cells and IZH2-mediated signaling pathways in S.
cerevisiae cells. (A) The components of the AdipoR1 signaling pathway of mammalian cells are shown in black font and their S. cerevisiae homologs,
if known are shown in red font. In mammalian cells, adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and
leucine zipper motif 1 (APPL1) interacts directly with AdipoR1. Interaction of adiponectin (ADPN) with AdipoR1 stimulates AdipoR1-APPL1 interaction.
This results in release of Ca2+ from the ER to the cytosol and also increases export of LKB1 kinase from the nucleus. Influx of extracellular Ca2+ to the
cytosol is also stimulated by adiponectin, although the mechanism by which this occurs remains to be clarified. Increase in cytosolic Ca2+
concentration activates Ca2+/calmodulin-dependent protein kinase kinase (CaMKK) which in turn activates AMP activated protein kinase (AMPK) by
phosphorylating its a subunit. However, phosphorylation of AMPK a subunit by the cytosol-localized kinase LKB1 is the major pathway for activation
of AMPK. Adiponectin-AdipoR1 interaction also increases cellular ceramidase activity which in turn leads to phosphorylation of AMPKa subunit. The
details of this pathway are not clear yet. Activation of AMPK is required for many of the anti-diabetic and anti-atherosclerotic effects of adiponectin. In
vascular endothelial cells, interaction of AdipoR1 with adiponectin activates protein kinase A (PKA) which has the effect of lowering accumulation of
reactive oxygen species (ROS) and thereby reducing inflammation. (B) Subunit structure of S. cerevisiae AMPK (ScAMPK). Like mammalian AMPK,
ScAMPK is a trimer composed of an a, b, and c subunit. The genes encoding the b subunit isoforms as well as the sole a and c subunits are indicated.
(C) Components of the IZH2-mediated signaling pathways in S. cerevisiae are shown in red font. Interaction of IZH2 (homolog of AdipoRs) with
osmotin (OSM) activates PKA via a RAS2-cAMP pathway. Overexpression of IZH2, overexpression of AdipoR1, treatment of S. cerevisiae cells expressing
AdipoR1 with adiponectin and treatment of S. cerevisiae cells expressing various levels of IZH2 with thaumatin (THN, a homolog of osmotin) has been
shown to activate PKA by increasing cellular ceramidase activity. Activation of PKA leads to decreased transcription from a stress responsive promoter
element (STRE) and increased cellular ROS content. Activated PKA promotes export of ScAMPK from the nucleus which leads to decreased
transcription from the ferroxidase (FET3) promoter. Activated PKA also represses FET3 transcription via the stress-responsive transcription factors
MSN2/4. Mutational analyses show that genes encoding the APPL1-lke protein Sip3, the LKB1-like protein Sak1, the ScAMPK b subunit Sip1 and the
ScAMPK c subunit Snf4 are components of the pathway leading from IZH2 (or AdipoR1) to FET3 repression in S. cerevisiae.
doi:10.1371/journal.pone.0065454.g001
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the corresponding sites in vector 35S-NLuc [33], yielding the
chimeric 35S-APPL1-NLuc construct. The APPL1-NLuc frag-
ment was then excised by digestion with SpeI and PstI and ligated
into p425-GPD cut with the same enzymes to generate the p425-
GPD-APPL1-NLuc construct. Construction of pESC-CLuc-Adi-
poR1 and pESC-CLuc-AdipoR2 was also performed in two steps.
CLuc was first introduced downstream of the GAL1 promoter in
pESC-URA and then AdipoR1 or AdipoR2 were fused in-frame
to CLuc. CLuc was amplified by PCR from the vector 35S-CLuc
using primers CLuc-F-BamHI and CLuc-R-XhoI-AscI-HindIII.
The PCR products were digested with BamHI and HindIII and
cloned into the cognate sites of pESC-URA, yielding pESC-CLuc.
Then the coding sequence of AdipoR1 and AdipoR2 were
amplified by RT-PCR from the total RNA using the primer pairs
AdipoR1-F-XhoI/AdipoR1-HindIII and AdipoR2-F-XhoI/Adi-
poR2-HindIII, respectively. The PCR products were digested with
XhoI and HindIII and ligated into pESC-CLuc digested with the
same enzymes to yield pESC-CLuc-AdipoR1 and pESC-CLuc-
AdipoR2. pESC-CLuc-AdipoR1-APPL1-NLuc that contains
GAL1-CLuc-AdipoR1 and GAL10-APPL1-NLuc in the same
vector was constructed as follows. APPL1-NLuc was amplified
from p425-GPD-APPL1-NLuc by PCR using the primer pair
APPL1-F-NotI/NLuc -R-ClaI. The PCR product was digested
with NotI and ClaI inserted into the cognate sites pESC-CLuc-
AdipoR1 yielding pESC-CLuc-AdipoR1-APPL1-NLuc. All con-
structs were verified by sequencing.
The pYES-EGFP-AdipoR1 and pYES-EGFP-AdipoR2 plas-
mids that contained EGFP fused in-frame to the N-terminus of
AdipoR1 and AdipoR2, respectively, were constructed as follows.
The entire AdipoR1 and AdipoR2 ORFs were amplified by PCR
from cDNA isolated from human THP-1 cells using the AdipoR1-
F-GFP/AdipoR1-R-GFP and AdipoR2-F-GFP/AdipoR2-R-GFP
primer pairs shown in Table S1. pYES-EGFP vector (digested
with BamHI and XhoI) mixed with the appropriate the PCR
product (digested with EcoR1 and Xho1) was transformed into S.
cerevisiae strain BY4741 for gap repair cloning. Positive clones were
confirmed by sequencing.
Osmotin, Adiponectin and Peptides
Osmotin was purified to homogeneity from suspension cultured
salt-adapted tobacco cells as described before [34]. Osmotin was
stored as sterile solution in ultrapure water (HPLC grade). The
osmotin preparation was determined to be over 99% homogenous
by 2D polyacrylamide gel electrophoresis and by mass spectrom-
etry. The IC50 (amount of osmotin that reduces growth by 50%)
was determined by literature methods [35] and ranged between 4–
8 mg/mL for the osmotin batches used in this study. Osmotin and
adiponectin were quantified using the BCA Protein Assay Reagent
(Pierce, Rockford, IL, USA) using bovine serum albumin as
standard. Unless specified otherwise, the pure recombinant
Escherichia coli expressed N-terminal (His)6-tagged full length
human adiponectin used in these studies was the gift of Dr. A.
Sharkhuu (KAUST, Saudi Arabia) or Dr. I. Sokolchik (Purdue
University, USA). The biological activity of endotoxin-free full
length human adiponectin batches used in this work was verified
by measuring its ability to induce apoptosis of MCF-7 breast
cancer cells or THP-1 monocytic leukemia cells [36,37].
Bacterially expressed human globular adiponectin (Biovendor,
Candler, NC, USA) and bacterially expressed recombinant full
length human adiponectin (Biovision, Mountain View, CA, USA
or Genway, San Diego, CA, USA) were used in some tests as
indicated in the figures. The synthetic cyclic peptides, OSMpep
and ZMTNpep, used in this worked were purchased from
American Peptide Company (Sunnyvale, CA, USA). Peptide
purity was 98% and they were dissolved in water at concentration
of 1 mg/mL.
Gene Expression Analysis by RT-PCR
Total RNA was prepared using the RiboPure-Yeast extraction
kit (Ambion, Grand Island, NY, USA) from 3 mL of overnight
culture grown in selective minimal medium and genomic DNA
contamination was eliminated using the TURBO DNA-free kit
(Ambion). cDNA was synthesized from total RNA (2 mg) using M-
MLV reverse transcriptase (Invitrogen, Grand Island, NY, USA).
The PCR primers used to amplify the target genes are listed in
Table S2. The PCR program was 2 min at 95uC followed by 25
cycles of 1 min of denaturation at 94uC, 2 min of annealing at a
temperature specific for each gene fragment (e.g. 54uC for ACT1
fragment) and 4 min of extension at 72uC. This was followed by
extension at 72uC for 7 min. PCR products were analyzed on a
1% agarose gel.
Luminescence Imaging and Luciferase Activity
Measurement
Cultures were grown overnight at 30uC in selective minimal
with 2% raffinose as carbon source. Cells were collected by 5 min
centrifugation at 6000 rpm, and cell pellets were washed with the
same medium but lacking sugar. Cells were resuspended at
A600 nm of 0.4 in selective minimal medium supplemented with
galactose or a galactose-raffinose mixture (2% sugar) as carbon
source and grown at 30uC for 16 h. The cultures were adjusted to
A600 nm of 0.4 and aliquots (100 mL) were centrifuged for 1 min at
16,0006g. Cell pellets were resuspended in 100 mL of 0.1 M Na
citrate buffer pH 3.0 containing 1 mM D-luciferin (Gold Biotech-
nology, St. Louis, MO, USA), and transferred to individual wells
of a 96-well plate (Nunc White polystyrene). The assay plate was
incubated for 5 min at room temperature in the darkness before
luminescence imaging under a CCD camera (Lumazone, Prince-
ton Instruments, USA) or for luciferase activity measurement using
a TECAN Ultra 96microplate reader. A unit of luciferase activity
was calculated as the luminescence value of sample minus the
luminescence value of blank solvent.
Measurement of b-Galactosidase Activity
For determination of b-galactosidase activity, cells were grown
in selective minimal medium to A600 nm of 0.4, resuspended in
YPD at A600 nm of 6.0 (ca. 10
8 cells/mL). Cells (1 mL) were then
mixed with water (0.2 mL) containing various amounts of osmotin
and incubated at 30uC with occasional mixing. Cells were
collected at the end of the incubation period by centrifugation
and resuspended in the same volume of ice cold Z buffer (60 mM
Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4,
50 mM 2-mercaptoethanol, pH 7.0). The A600 nm of the cell
suspension was measured and adjusted to 1.0 by the addition of
more ice cold Z buffer. Cells (0.1 mL) were mixed with Z buffer
(0.9 mL), chloroform (0.1 mL) and 0.1% SDS (5 mL), vortexed for
10 sec and then subjected to three freeze-thaw cycles (liquid
nitrogen 30 sec–37uC 90 sec). The suspension of broken cells was
warmed to 28uC and enzyme activity was initiated by addition of
o-nitrophenyl-b-D-galactopyranoside (0.2 mL of 4 mg/mL solu-
tion). The reaction was allowed to proceed at 28uC for various
time periods and then terminated by addition of 1 M sodium
carbonate solution (0.5 mL). The suspension was clarified by
centrifugation and the absorbance of the supernatant was
measured at 420 nm. One unit of b-galactosidase activity was
defined as 1000 X (DA420 nm/min/A600 nm).
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Immunoblot Analysis
For examining the expression of EGFP-tagged AdipoRs,
cultures were grown as described under ‘Luminescence Imaging
and Luciferase Activity Measurement’. Total protein extracts were
prepared from cells grown on 2% galactose in yeast extraction
buffer (50 mM Tris-HCl pH 8.0, 50 mM NaCl, 5% glycerol,
1 mM each of EDTA, phenylmethylsulfonyl fluoride, and
dithiotheritol, 0.5 mg/mL each of pepstatin, aprotinin, and
leupeptin) as previously described [38]. One hundred mg of
membrane proteins were fractionated by 10% SDS-PAGE and
transferred to a polyvinylidene difluoride (PVDF) membrane
(Immobilon P; Millipore). EGFP was visualized by the ECL
method (GE Healthcare, UK) using monoclonal antibody to GFP
as primary antibody (Clontech, Mountain View, CA, USA) and
horseradish peroxidase-conjugated secondary antibody.
For examining the phosphorylation of S. cerevisiae AMPKa
subunit (Snf1p), cells were grown and treated with osmotin (or
adiponectin) exactly as described under ‘Measurement of b-
Galactosidase Activity’. Treated cells were broken by trichlor-
oacetic acid (TCA) protein extraction method and cell-free
extracts were fractionated by SDS-PAGE on 10% polyacrylamide
gels. After transfer to nitrocellulose membranes (Millipore, Bill-
erica, MA, USA), phospho-Snf1p was detected by the ECL
method (Thermo, Rockford, IL, USA) using monoclonal antibody
to phospho-AMPKa (Thr172) as the primary antibody (Cell
Signaling, Danvers, MA, USA) and goat anti-rabbit horseradish
peroxidase as secondary antibody. Band intensities were measured
on Luminescent Image Analyzer LAS-4000 with Multi Gauge
V3.0 program (Fuji film, Tokyo, Japan). For determination of
osmotin sensitivity, cells were washed three times with YPD at the
end of the incubation period and serial dilutions in water were
spotted on YPD agar plates.
Confocal Microscopy
Cells expressing EGFP-tagged receptors were grown as
described under ‘Luminescence Imaging and Luciferase Activity
Measurement’. Cells grown in 2% galactose were fixed by
incubating in 0.1% formaldehyde at room temperature for
25 min. After washing 3 X with 0.1 M sodium phosphate buffer
containing 0.137 M NaCl (pH 6.5), cells were re-suspended in the
same buffer and stained for 5 minutes with DAPI (0.5 mg/mL) in
the dark at room temperature. Cells were examined and
photographed under a confocal laser-scanning microscope (Zeiss
LSM 510 META).
Computational Studies
Details on homology modeling, MD simulations and docking
studies are given in Methods S1. In brief, the 3D-homology model
of human AdipoR1 was built for amino acids 135–364 with the
Schro¨dinger suite 2011 using archeal (Natronomonos pharaonis)
phototaxis protein rhodopsin II (PDB id: 1GU8) as template
structure [39]. The resulting homology model of AdipoR1 was
embedded in 1,2-dipalmitoylphosphatidylcholine (DPPC) mem-
brane and subjected to minimization and MD relaxation
[GROMACS 4.5.5 software package and GROMOS53a6 force
field [40]. The 3D structure of the globular domain of human
adiponectin (residues 105–254) was built using the YASARA
structure molecular modeling package [41] using a murine isoform
(PDB id: 1C3H) as template [42]. Energy minimization and MD
relaxation was performed using Yasara scripts. For docking of
protein and peptide/AdipoR1 complexes PATCHDOCK and
FireDock were used. Resulting complexes were energy minimized
and analyzed following MD simulation (GROMACS).
Results
Adiponectin Receptors are Expressed on the Surface of
Yeast Cells
We first confirmed the correct localization of AdipoRs in
plasma membranes of S. cerevisiae by fluorescence microscopy using
EGFP-AdipoR fusion proteins. As shown in Figure 2, cells of the
wild type S. cerevisiae strain BY4741 transformed with a multicopy
plasmid expressing EGFP under the GAL promoter displayed a
diffuse intracellular fluorescence suggestive of cytoplasmic locali-
zation. However, cells expressing EGFP-AdipoR1 or EGFP-
AdipoR2 from the same plasmid vector exhibited a strong
fluorescence on the surface that was absent in control cells
expressing only EGFP, suggesting plasma membrane localization
of the recombinant AdipoRs. Fluorescence was also observed in
vesicles that resembled the pre-vacuolar compartment, possibly
due to degradation of AdipoR1 and AdipoR2 in the vacuole.
Expression of EGFP-AdipoR1 (65 kDa), EGFP-AdipoR2 (65 kDa)
and EGFP (26 kDa) was confirmed by Western blot analysis of
cell-free extracts with an anti-GFP antibody.
Strategy for Reporting Adiponectin-AdipoR1 Interaction
In mammalian cells, APPL1 directly interacts with the
intracellular N-terminal sequence of AdipoR1 [43,44]. AdipoR1-
APPL1 interaction is stimulated by adiponectin and it triggers the
activation of AMPK in mammalian cells (Figure 1). APPL1 also
interacts with AdipoR2 [43], but downstream signaling resulting
from the AdipoR2-APPL1 interaction is not well-understood.
Since ligand-stimulated AdipoR1-APPL1 interaction is the earliest
known step in the adiponectin-AdipoR signaling cascade, we
decided to use it as the basis for our S. cerevisiae-based assay
targeting AdipoR1-ligand interactions. We selected the split-
luciferase bimolecular complementation assay as reporter system
for AdipoR1-APPL1 contacts, since it is a well-established method
for studying protein-protein interactions in mammalian, plant and
S. cerevisiae cells [45,46,47]. Accordingly, a chimeric gene encoding
human APPL1 fused in-frame at its C-terminus to firefly luciferase
fragment 2-416 (NLuc) was cloned into the multiple cloning site 1
of the vector pESC-URA to yield the control plasmid pESC-URA-
APPL1-NLuc (Figure 3A). This plasmid allows the expression of
APPL1-NLuc from the GAL10 promoter. Similarly, a second
chimeric gene encoding firefly luciferase fragment 398–550 (CLuc)
fused to the N-terminus of AdipoR1, and inserted into the multiple
cloning site 2 of the vector pESC-URA, yielded the control
plasmid pESC-URA-CLuc-AdipoR1 (Figure 3A). This plasmid
allows the expression of CLuc-AdipoR1 from the GAL1 promoter.
Both chimeric proteins, CLuc-AdipoR1 and APPL1-NLuc,
contained a linker between the two fragments to confer some
mobility to the luciferase domains thus facilitating reconstitution of
luciferase activity. The test plasmid pESC-URA-CLuc-AdipoR1-
APPL1-NLuc for simultaneous expression of both the chimeric
proteins, APPL1-NLuc and CLuc-AdipoR1, was then constructed
from these two control plasmids using gap repair cloning. All
plasmids were transformed into S. cerevisiae strain BY4741 for
expression test.
Proof-Of-Concept: Receptor Level-Dependent
Reconstitution of Luciferase Activity
It has been reported that overexpression of IZH2 and AdipoR1
can activate downstream signaling leading to suppression of FET3
promoter-dependent transcription even in absence of a ligand
(Figure 1) [26,48]. Therefore, to prove that the bi-molecular
complementation assay based on split-luciferase was functional, we
performed luminescence imaging of colonies after full induction of
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the GAL1 and GAL10 promoters by 2% galactose in the growth
media. It can be seen (Figure 3B) that upon application of the
substrate, D-luciferin, only transformants carrying the test plasmid
pESC-URA-CLuc-AdipoR1-APPL1-NLuc exhibited lumines-
cence whereas transformants carrying either the vector pESC-
URA, or the control plasmids pESC-URA-CLuc-AdipoR1 and
pESC-URA-APPL1-NLuc did not. Next, we studied whether the
obtained reporter gene activity is proportional to the expression
levels of AdipoR1 and APPL1. First, expression levels of both
AdipoR1 and APPL1 in the pESC-URA-CLuc-AdipoR1-APPL1-
NLuc transformant were confirmed to increase in proportion to
the galactose concentration in the growth medium (Figure 4A).
Next, assays performed in microtiter plates showed that luciferase
activity in pESC-URA-CLuc-AdipoR1-APPL1-NLuc transfor-
mants increased as a function of galactose concentration in the
medium (Figure 4B). Again, no significant luciferase activity could
be detected in controls that expressed only one or none of the
interaction partners (Figure 4B). These results indicated that the
reporter activity directly correlated with the amounts of the
interacting partners.
Among the IZH family proteins, Izh2p has most homology with
AdipoRs (about 32% amino acid sequence identity). Therefore, we
examined whether IZH2 maybe interfering with the AdipoR1-
APPL1 interaction resulting in a reduced luciferase reporter
activity. As shown in Figure 4C, luciferase activity was increased
significantly by inactivation of IZH2. This effect was observed in
cells grown in 1%, 1.5% and 2% galactose, indicating that Izh2p
competes with AdipoR1 for binding to APPL1. The putative
ortholog of APPL1 in S. cerevisiae is Sip3p and genetic evidence
supports a role of SIP3 in IZH2 signaling (Figure 1) [26]. However,
inactivation of SIP3 did not significantly increase luciferase activity
indicating that Sip3p does not compete with APPL1 for AdipoR1
binding (Figure 4C).
Demonstration of Adiponectin- and Osmotin-Induced
Increase in Luciferase Activity
Next, we tested whether incubation of galactose-induced cells
with AdipoR1 ligands further stimulated luciferase reporter
activity. In addition to adiponectin, we also used osmotin as a
test ligand. Osmotin is a tobacco defense protein that has been
shown to be a structural and functional homolog of adiponectin
[29]. Specifically, osmotin stimulates AMPKa phosphorylation in
an AdipoR-dependent manner in murine skeletal muscle cells and
also stimulates IZH2-dependent intracellular signaling in S.
cerevisiae [29]. While direct binding of adiponectin and osmotin
to AdipoRs has not yet been observed experimentally, homology
model based docking results confirm that complexes of both
proteins with the extracellular surface of AdipoR1 are energeti-
cally favorable [49].
Luciferase activity of galactose-induced pESC-URA-CLuc-
AdipoR1-APPL1-NLuc carrying cells of strain BY4741 was
increased upon additional incubation with either globular
Figure 2. AdipoRs are expressed on the plasma membrane in S. cerevisiae. (A) Subcellular localization of AdipoRs by confocal microscopy. S.
cerevisiae strain BY4741 carrying plasmid pYES-EGFP (GFP), pYES-EGFP-AdipoR1 (GFP-AdipoR1) and pYES-EGFP-AdipoR2 (GFP-AdipoR2) were cultured
in selective minimal medium containing 2% galactose. Shown are images of cells that were in the early log phase of growth. (B) Western blot analysis
of total membrane protein extracts that were fractionated by 10% SDS-PAGE. The predicted molecular weights of GFP-AdipoR1 and GFP-AdipoR2 are
around 65 kDa.
doi:10.1371/journal.pone.0065454.g002
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adiponectin, full length adiponectin from two sources or osmotin,
compared to incubation with solvent (1/8 X PBS) (Figures 5A and
S1). On the other hand, the luciferase activity remained constant
upon additional incubation with the negative control protein
Bovine Serum Albumin (BSA) compared to incubation with
solvent (Figure 5A), indicating that the luciferase activity was
stimulated specifically by the predicted ligands of AdipoR1 [49].
These results also agree with experiments showing that AdipoR1-
signaling is initiated by bacterially expressed full length adipo-
nectin, globular adiponectin and osmotin [21], [29]. Ligand-
induced increase in luciferase activity was observed only upon
achieving a detectable signal even in absence of added ligand,
requiring cells to be induced with 1–2% galactose (Figures 5A and
S1). Next, we quantified luciferase activity in cells induced with
different galactose concentrations after incubation with a range of
osmotin concentrations (Figure 5B). The results confirmed that
ligand-induced luciferase activity was observed only in cells that
were grown at or above 1% galactose. Luciferase activity was
approximately the same at 1% and 1.5% galactose and also did
not vary within the range of osmotin concentrations tested (3.2–
12.8 mM).
Evaluation of Thaumatin Like Protein (TLP)-Based
Peptides as Ligands of AdipoR1
A nine residue cyclic osmotin-derived peptide (OSMpep,
Table 1) was predicted to interact with AdipoR1 on the basis of
molecular modeling studies and then shown to induce AdipoR1-
Figure 3. The split firefly luciferase complementation colony assay for AdipoR1 and APPL1 interaction. (A) Schematic representation of
the plasmid vector constructs. CLuc-AdipoR1 was cloned into the multiple cloning site 2 (MCS2, green shadow) of pESC-URA for expression from the
GAL1 promoter and Appl1-NLuc was cloned into MCS1 (orange shadow) of pESC-URA for expression from the GAL10 promoter. pESC-URA-CLuc-
AdipoR1-APPL1-NLuc (not shown) contains the depicted APPL1-NLuc construct inserted between Not1 and Sac1 sites of the MCS1 of pESC-URA-
CLuc-AdipoR1. (B) Visualization of the AdipoR1-APPL1 interaction in colonies. Cells of strain BY4741 untransformed (No plasmid) or transformed with
the indicated plasmids were spread on minimal medium lacking uracil containing 2% galactose. After 2 days incubation at 30uC, plates were
photographed before (–) and imaged after (+) spraying with D-luciferin.
doi:10.1371/journal.pone.0065454.g003
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dependent intracellular signaling in mammalian cells [49]. This
peptide is structurally stable and rigid and the simulation of its
interaction with AdipoR1 predicted that it binds to the same
region of AdipoR1 as adiponectin [49]. Proteins with sequence,
structure and serological similarity to osmotin are ubiquitous in
plants and are referred to as thaumatin-like proteins (TLPs). We
hypothesized that the homologs of OSMpep from other TLPs
such as soybean P21, banana TLP, thaumatin, kiwi Act d2 and
corn zeamatin may bind as well or better to AdipoR1 as OSMpep.
These TLPs were selected as the source of peptide sequences for
the following reasons: (i) the structures of osmotin, banana TLP,
thaumatin and zeamatin have been determined by X-ray
crystallography (Table 1), so many of the selected peptides are
confirmed to exist in a similar structural context in all the TLPs;
(ii) thaumatin and osmotin have been shown to stimulate IZH2-
dependent signaling in S. cerevisiae and many TLPs have antifungal
activity, rendering it possible that some of these peptides might
have biological activity [29,48,50,51]. We tested our hypothesis
using a molecular modeling approach. Building on the strategy of
Miele et al., [49], we were able to create a membrane embedded
AdipoR1 homology model covering amino acids 135–364 of
human AdipoR1. The 11 additional C-terminal amino acids in
our model compared to that of Miele et al., [49] provided an
extended 7th transmembrane helix which reached up to the
receptor’s binding site. This homology model served as basis for
docking studies of adiponectin and osmotin on AdipoR1 and to
predict TLP peptide-AdipoR1 interactions and possible TLP
binding (Figures S2 and S3). Shortly after we had finished our
molecular modeling studies, a crystal structure of an engineered
single-chain trimer human adiponectin globular domain was
published (PBD id: 4DOU) [58]. The structure is in excellent
agreement with our homology model for human globular
adiponectin with a nearly identical geometry of the binding site
residues (Figure S3G). Our homology model and engineered
trimeric templates [52]lead to nearly identical docking results.
All ligand/AdipoR1 interactions predicted by our model took
place at the same overall binding site, which was formed by a
central cleft between the 3 extracellular loops and extended to the
C-terminal 7th transmembrane helix of AdipoR1. Our membrane
embedded model gave clear indications, identifying AdipoR1
Figure 4. Luciferase reporter activity depends on the expression level of AdipoR1 and APPL1. (A) RT-PCR analysis of AdipoR1 and APPL1
expression in total RNA (2 mg) from cells of strain BY4741 carrying pESC-URA-CLuc-AdipoR1-APPL1-NLuc that were grown for 16 h at 30uC in selective
minimal medium at the indicated galactose concentrations. The final concentration of sugars in the growth media was adjusted to 2% with raffinose.
ACT1 expression is shown for normalization. (B) Quantification of luciferase activity in BY4741 cells carrying pESC-URA, pESC-URA-CLuc-AdipoR1,
pESC-URA-APPL1-NLuc and pESC-URA-CLuc-AdipoR1-APPL1-NLuc plasmids. Cells were grown for 16 h at 30uC in selective minimal medium at the
indicated galactose concentrations. Luciferase activity measurements were made as described in Methods. (C) Imaging (top) and quantification of
luciferase activity (bottom) in pESC-URA-CLuc-AdipoR1-APPL1-NLuc transformants of strain BY4741 (Parent) or its isogenic izh2D and sip3D derivative
strains. Assays were performed as described above on cells that were grown for 16 h at 30uC in selective minimal medium at the indicated galactose
concentrations. Results are expressed as the mean 6 SD from three separate experiments with triplicate samples. Significant difference from the
parent strain is indicated by asterisks. Symbols: **, p,0.01; ***, p,0.001.
doi:10.1371/journal.pone.0065454.g004
Assay Method for Ligand-Mediated AdipoR Signaling
PLOS ONE | www.plosone.org 8 June 2013 | Volume 8 | Issue 6 | e65454
residues that can participate in binding. For example, one top
scoring complex for the docking of osmotin to the membrane free
receptor model [49] was omitted in our membrane embedded
model, because part of the interaction took place on the
membrane-covered surface of AdipoR1. Although our membrane
embedded model and the membrane free receptor model [49]
predict similar overall architectures of complexes and binding
sites, we found clear differences in the residues involved in ligand/
AdipoR1 interactions (see Figures S4 and S5 for details).
Compared to the earlier model [49], the interacting region of
AdipoR1 in our model was generally shorter on loop 1, shifted to
toward the C-terminus on loop 3, and extended on loop 5. We also
found a weak C-terminal interaction. However amino acids G354
and V355 of AdipoR1, which are predicted to be interacting
residues in the model of Miele et al., [49] were found to be
membrane embedded and hence not accessible in our model.
Overall, extension of helix 7 and membrane embedding led to
important differences in the prediction of ligand binding sites on
AdipoR1.
The docking scores received for the tested TLP peptides suggest
that the osmotin derived peptide (OSMpep) has the highest
binding affinity to AdipoR1, while the zeamatin derived peptide
(ZMTNpep) is the weakest binding ligand (Table 1). However,
OSMpep and ZMTNpep interact in a very similar way with the
Figure 5. The AdipoR1 ligands, adiponectin and osmotin, induce increase in Luc reporter activity. Cells of strain BY4741carrying pESC-
URA-CLuc-AdipoR1-APPL1-NLuc were grown for 16 h at 30uC in selective minimal medium at the indicated galactose concentrations, treated for 4 h
at 30uC with the indicated test compounds and then assayed for Luc activity. (A) Imaging of Luc activity. (B) Quantitative measurement of Luc activity
as a function of osmotin concentration. A representative image of relative Luc activity at the different osmotin concentrations is shown for each
galactose concentration. Data represent the means 6 SD from three experiments with triplicate samples. For each galactose concentration,
significant differences by a Student’s t-test between osmotin treated samples and untreated control are indicated by asterisks. Symbols: PBS, 1/8 X
PBS; f-ADPN, bacterially expressed full length adiponectin; BSA, bovine serum albumin, OSM, osmotin; g-ADPN, bacterially expressed globular
adiponectin; **, p,0.01; ***, p,0.001.
doi:10.1371/journal.pone.0065454.g005
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AdipoR1 binding site, which also strongly resembles the AdipoR1-
osmotin interaction (Figures 6, S3D, S4 and S6). We tested the
model prediction experimentally using the split luciferase assay
described above. The assay was performed in the izh2D mutant to
avoid possible interference by Izhp. As shown in Figure 6D, the
luminescence intensity of pESC-URA-CLuc-AdipoR1-APPL1-
NLuc transformed cells treated with osmotin or OSMpep was
significantly greater than that of cells treated with PBS or
equivalent concentration of ZMTNpep. Thus, computational
predictions and experimental results are in agreement, which
suggests that the split luciferase assay is able to discriminate
between good and poor ligands of AdipoR1.
Osmotin Signaling Mediated by Adiponectin Receptors
Results in Phosphorylation of Snf1p
AMPKs have conserved structure and are essential for control
of energy metabolism in yeast, plants and mammals [24,25]. The
catalytic activity of AMPKs is upregulated by phosphorylation of a
conserved Thr residue on the catalytic a subunit. Phosphorylation
of murine AMPKa subunit on this conserved Thr172 by
adiponectin or osmotin is abrogated by silencing the expression
of adiponectin receptors in cultured murine myotubes [29]. Snf1p
is the sole AMPKa subunit present in the S. cerevisiae proteome and
it is activated by phosphorylation at the conserved threonine,
Thr210, in response to glucose starvation or stress [25]. To
examine whether osmotin and adiponectin can stimulate Adi-
poR1- or AdipoR2-dependent phosphorylation of Snf1p at
Thr210, we determined the cellular content of phospho-Snf1p in
osmotin- or adiponectin-treated cells of strain BWG1-7a that were
expressing AdipoR1 or AdipoR2 constitutively from a multicopy
plasmid (Figure S7). No significant increase in phospho-Snf1p
levels were observed in empty vector, pAdipoR1 or pAdipoR2
transformants after osmotin or adiponectin treatments. This
suggested that IZH2 could be interfering with AdipoR1-depen-
dent Snf1-activation signaling, just as it interferes with APPL1-
dependent AdipoR1signaling (Figure 4C). Therefore we repeated
this experiment using an izh2D mutant of strain BWG1-7a. We
found the cellular content of Thr210-phosphorylated Snf1p was
unaffected by osmotin or adiponectin treatments in an izh2 mutant
transformed with the empty vector (Figure 7). Constitutive
expression of AdipoR1 or AdipoR2 from the same multicopy vector
resulted in a time- and concentration-dependent increase in Snf1p
phosphorylation at Thr210 in response to osmotin or adiponectin
treatments (Figures 7 and S8). These results demonstrated that
AdipoR1 and AdipoR2 signaling in yeast and mammalian cells
share an important common element, namely, the activation of
AMPKa by phosphorylation. They also showed that IZH2
interferes with the AdipoR signaling that leads to Snf1p activation
in S. cerevisiae.
Osmotin-AdipoR Signaling Results in Suppression of
Gene Expression via Stress Responsive Promoter
Elements
IZH2-mediated osmotin signaling activates the PKA pathway
resulting in suppression of transcription from stress responsive
promoter elements (STRE, 59-CCCCT-39). Mutation of IZH2
abrogates this effect [29] and conversely, overexpression of IZH2
suppresses transcription from STREs [26]. Accordingly, we
observed that osmotin was unable to suppress STRE-lacZ
expression in an izh2D mutant co-transformed with pSTRE-
lacZ(LEU) and p426-GPD vector (Figure 8). However, in an izh2D
mutant co-transformed with pSTRE-lacZ(LEU) and p426-GPD-
AdipoR1 or p426-GPD- AdipoR2, STRE-lacZ expression was
suppressed by osmotin treatment. Therefore AdipoR1 and AdipoR2
resemble IZH2 in their ability to activate ligand-dependent
signaling via the PKA pathway in S. cerevisiae.
Discussion
We describe here a S. cerevisiae based system for investigating
ligand/AdipoR1 interactions that lead to cellular signaling. The
three-parts system consists of a split luciferase assay for reporting
ligand-AdipoR1 interactions and assays to verify ligand-AdipoR
mediated activation of Snf1p (yeast AMPKa) phosphorylation and
PKA signaling pathways. Since adiponectin-AdipoR dependent
activation of AMPKa phosphorylation and PKA signaling
mediate anti-diabetic and cardioprotective effects of adiponectin,
our S. cerevisiae based system has the potential to facilitate the
discovery of AdipoR ligands with therapeutic value.
Besides osmotin and OSMpep [50], there are no known ligands
of AdipoR1. Since osmotin and plant TLPs have similar structure
and biological activity, and OSMpep is quite conserved between
plant TLPs, we performed a comparative analysis of the binding of
several homologs of OSMpep to membrane embedded AdipoR1
and were able to validate the ability of the split luciferase assay to
discriminate between ligands based on the strength of their
Table 1. Docking score for peptides docked in AdipoR1.
Ligand Protein/source of purified protein PDB/UniProt Peptide sequenceg score Ebind (kcal/mol)
OSMpep Osmotina/Salt adapted tobacco cells 1PCV/P14170 CTQGPCGPT 28.21 294.89
P21pep P21b/ Soybean leaf CNSGSCGPT 27.25 278.21
BANpep Ban-TLPc/banana fruit/ 1Z3Q/O22322 CNSGSCSPT 26.45 276.88
THNpep Thaumatind/Thaumatococcus danielli
(katemfe) fruit
1THV/P02883 CTTGKCGPT 26.82 288.72
ACTd2pep Act d2e/Kiwi fruit/ 2/P81370 CNSGNCGLT 25.91 276.49
ZMTNpep Zeamatinf/corn kernel/ 1DU5/P33679 CVGSAANDCHPT 25.95 271.48
a[56];
b[57];
c[58];
d[59];
e[60];
f[61];
gdisulfide-bonded cyclic peptides.
doi:10.1371/journal.pone.0065454.t001
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binding to AdipoR1 (Figure 6 and Table 1). It should be noted
that two biologically active adiponectin peptides that have been
described [59,60] encompass residues that are predicted to interact
with AdipoR1 by our model and by the earlier model (Figure S5)
[50].
Split luciferase complementation assays have been successfully
used to study protein-protein interactions in mammalian and plant
systems but are used less frequently in S. cerevisiae. Our results show
that they can be used to demonstrate protein-protein interactions
in whole colonies of S. cerevisiae as well as in cells in liquid culture.
We decided to base our assay for investigating ligand-AdipoR1
interactions on the first protein-protein interaction of AdipoR1
that is known to trigger downstream signaling underlying the anti-
diabetic and cardioprotective effects of adiponectin, i.e. the
interaction between AdipoRs and the coupling protein APPL1
(Figure 1) [43,53]. The split luciferase assay could possibly be
optimized further by controlling relative expression levels of
AdipoR1 and APPL1, for example, by expressing them from
promoters regulated by different stimuli. In fact when the signal
strengths in response to adiponectin are compared in 1%
Figure 6. Comparison of TLP-derived peptide ligands binding to AdipoR1. 3D model of (A) OSMpep and (B) ZMTNpep bound to AdipoR1.
Peptides are shown in ball and stick representation (C atoms in green). The interacting residues of AdipoR1 are shown as sticks only (interacting
residues: C in gray; non-interacting residues: C in purple). Atom color coding is white =H, red=O, blue =N, yellow=S. (C) Overlay of osmotin (red)
and the three top scoring OSMpep poses (peptide strands in green, purple and orange illustrate orientation of poses with 1st, 2nd and 3rd highest
docking score) bound to AdipoR1 (blue). (D) Verification of interaction strength of the peptides with AdipoR1 by the split luciferase assay. Cells of
strain BY4741carrying pESC-URA-CLuc-AdipoR1-APPL1-NLuc were grown for 16 h at 30uC in selective minimal medium containing 1.5% galactose,
treated for 4 h at 30uC with the indicated test compounds and then used for luciferase activity measurement. The concentrations of test compounds
in the assay were: PBS, 1/8 X PBS; ZMTNpep, 80 mg/mL; osmotin, 80 mg/mL (3.1 mM) and OSMpep, 80 mg/mL. Shown is a representative image of
luciferase activity and quantification of the luminescence under the CCD camera. Data are the mean 6SD from three separate experiments with
triplicate samples. Asterisks represent significant differences at **, p,0.01 by Student’s t-test.
doi:10.1371/journal.pone.0065454.g006
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galactose-grown S. cerevisiae cells transformed with pESC-URA-
CLuc-AdipoR1-APPL1-NLuc, in which CLuc-AdipoR1 and
APPL1-NLuc are expressed under the inducible GAL1 and
GAL10 promoters on the high copy number p-ESC-URA vector
(Figure 5) and in S.cerevisiae cells co-transformed with pESC-URA-
CLuc-AdipoR1 and p425-GPD-APPL1-NLuc where the only
difference is that APPL1-NLuc is expressed from the constitutive
GPD promoter on the high copy number p425-GPD vector
(Figure S9), the response to adiponectin is greater in the latter
instance. Our preliminary results suggest that the split luciferase
assay can be adopted for reporting ligand-AdipoR2 interactions
(Figure S9). Therefore, with optimization and adaptation to
robotic plating and washing, the split luciferase assay has the
potential to be useful for screening chemical libraries for candidate
AdipoR ligands.
APPL1 is a 709 amino acids protein that - ordered from the N-
to the C-terminus - consists of BAR (Bin/Amphiphysin/Rvs), PH
(plekstrin homology), BPP (between PH and PTB), PTB
(phosphotyrosine binding) and CC (coiled coil) domains [54].
Sip3p is the closest structural relative of APPL1 in S. cerevisiae,
consisting of 1229 amino acids and having only a PH domain
(amino acids 310–423) in common with APPL1. Sip3p was
identified as a transcriptional activator that interacts with DNA-
bound Snf1p [55]. Inactivation of SIP3 abrogates IZH2- and
AdipoR-dependent repression of FET3 promoter activity in S.
cerevisiae [26] (Figure 1). These data, and the fact that the PH
domain of APPL1 which is known to mediate AMPK phosphor-
ylation in mammalian cells [43] is conserved in Sip3p, led us to
consider the possibility that Sip3p could interfere with the
AdipoR1-APPL1 interaction. However, our results show that
Sip3p does not interfere with the APPL1-AdipoR1 interaction
Figure 7. Osmotin signaling mediated by adiponectin receptors induces Snf1p phosphorylation in an izh2D mutant. (A) Cell lysates
(100 mg protein) of strain BWG1-7a and an isogenic Dsnf1::Kan_MX line were fractionated by 10% SDS-PAGE. Shown are blots probed with anti-
phospho-AMPK(Thr-172) antibody. The expected size of Snf1p is 72 kDa. (B, C) Cells (about 108/mL) of strain BWG1-7a Dizh2::Kan_MX transformed
with p426GPD (Vec), p426GPD-AdipoR1 (pAdipoR1) or p426GPD-AdipoR2 (pAdipoR2) were treated with indicated osmotin and adiponectin
concentrations for 30 min at 30uC in YPD. Aliquots were withdrawn for viable counts determination before the cell lysates were prepared for analysis
by10% SDS-PAGE. Shown in the top panels are blots probed first with phospho-AMPK(Thr-172) antibody, then stripped and probed with actin
antibody (100 mg total protein per lane). Shown in the middle panels are relative band intensities in the depicted gels. ‘Relative band intensity’ was
defined as the ratio of the intensity of phospho-Snf1p signal to actin signal for each lane when the value of this ratio for the corresponding untreated
Vec sample was arbitrarily assigned the value 1.0. Shown in the bottom panels are viable counts in each sample at the end of the treatments. The
experiments were performed twice with comparable results and the results of one experiment are shown.
doi:10.1371/journal.pone.0065454.g007
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(Figure 4C). This is not surprising, since the overall homology
between APPL1 and Sip3p is very low and Sip3p also lacks the
PTB domain that mediates AdipoR1-APPL1 interaction. Overall,
our results suggest that while Sip3p participates in the Snf1p
pathway leading to transcriptional regulation of SUC2 (invertase)
and in the pathway leading from IZH2 or AdipoRs to transcrip-
tional regulation of FET3 [26,55], it not does not compete with
APPL1 for interacting with AdipoR1. APPL1 is required for
adiponectin mediated AMPKa activation in mammalian cells
[43], but was not required for adiponectin-AdipoR-mediated
Snf1p activation in S. cerevisiae (Figure 7). Further experiments are
necessary to clarify whether Sip3p or some S. cerevisiae protein(s)
other than Sip3p substitutes for APPL1 function in the pathway
from AdipoRs to Snf1 phosphorylation in yeast or whether an
APPL1-like function is not required in this pathway.
Among the S. cerevisiae IZH family proteins, Izh2p is the most
closely related member to AdipoRs (about 32% amino acid
sequence identity) with Izh1p being next (about 29% amino acid
sequence identity). Izh3p and Izh4p have less than 15% amino
acid sequence identity with AdipoRs. Genetic evidence suggests
that the AdipoRs as well as the IZH family members, IZH1, IZH2,
IZH3 and IZH4, function in the same signaling pathway that leads
to transcriptional regulation of FET3 in S. cerevisiae [26].
Accordingly, inactivation of IZH2 increased the signal in the split
luciferase assay of AdipoR1-APPL1 interaction (Figure 4C)
indicating that Izh2p competes with AdipoR1 for APPL1. Indeed,
we were able to directly verify Izh2p/APPL1 interaction by
demonstrating that luciferase activity increased as a function of
galactose concentration in the growth medium for cells of strain
BY4741 co-transformed with pESC-URA- CLuc-IZH2 and
p425GPD-APPL1-NLuc (Figure S9C). IZH2 interfered with
signaling leading from AdipoRs to the activation of Snf1p
phosphorylation (compare Figures 7 and S7). It is therefore
possible that the signal strength or/and specificity for AdipoR1 in
our S. cerevisiae based assays for ligand-AdipoR1 interactions could
be further improved by performing experiments in a yeast strain
lacking both IZH2 and IZH1 or all four IZH genes.
In the izh2 mutant expressing AdipoR1, both osmotin and
adiponectin were able to activate Snf1p phosphorylation. On the
other hand, in the izh2 mutant expressing AdipoR2 only
adiponectin was able to activate Snf1p phosphorylation. Our
previous results have indicated that AdipoR1 or AdipoR2
contribute equally to stimulation of AMPK phosphorylation in
response to osmotin and adiponectin treatments in the immortal-
ized murine C2C12 myogenic cell line [29]. Also both AdipoR1
and AdipoR2 appear to be equally functional in the pathway
leading from osmotin to STRE-lacZ expression (Figure 8). So how
does one explain the inability of osmotin-AdipoR2 to stimulate
Snf1p phosphorylation in S. cerevisiae? First, the apparent equal
contribution of AdipoR1 and AdipoR2 to adiponectin and
osmotin mediated AMPK phosphorylation in the C2C12 immor-
talized mouse myoblast cell line and STRE-lacZ expression in
yeast must be viewed with caution because only one concentration
of each agonist was used in these experiments. Second, it is
important to recognize here that several factors contribute to the
nature and amplitude of signaling output from adiponectin [20].
These include the molecular form (globular, full length, glycosy-
lated full length) of adiponectin, the relative proportion of
AdipoR1 and AdipoR2 in the plasma membrane, the relative
abundance of different downstream signaling components in
different cell types, differences in the affinities of the two receptors
for a given intracellular signaling molecule and differences in
signaling networks in different cell types. Therefore it is very
difficult to extrapolate results from one set of conditions to
another. However, we can provide one explanation to reconcile
the apparent discrepancies between the ability of AdipoR1 and
AdipoR2 to contribute to osmotin-induced Snf1p phosphorylation
in S. cervisiae (Figure 7) and C2C12 myocytes [29] based on the
known differences in the affinities of AdipoRs for different
molecular forms of adiponectin [21]. AdipoR1 binds to globular
adiponectin with high affinity and to bacterially expressed full
length adiponectin with low affinity whereas AdipoR2 binds to
both these forms of adiponectin with medium affinity [21]. We
used bacterially expressed full length adiponectin in all of the
experiments in this study. If we postulate that the strength of
Snf1p/AMPKa phosphorylation is governed solely by the binding
affinity of ligand for AdipoRs, we can expect somewhat
comparable effects for the induction of Snf1p phosphorylation
by full length adiponectin-AdipoR1and full length adiponectin-
AdipoR2 in S. cerevisiae, as observed (Figure 7). Osmotin and
globular adiponectin lack the N-terminal collagen domain of full
length adiponectin and therefore do not exist as hexamers like full
length adiponectin. Therefore the affinity of osmotin for AdipoR1
would exceed its affinity to AdipoR2, as is the case for globular
adiponectin, resulting in significantly greater osmotin-induced
Snf1p phosphorylation in S. cerevisiae cells expressing AdipoR1
than in cells expressing AdipoR2 (Figure 7). On the other hand,
we used globular adiponectin and osmotin in our previous study
[29] and observed, accordingly, that silencing of either AdipoR1
or AdipoR2 had the same effect on osmotin- and adiponectin-
induced AMPKa phosphorylation. The discrepancy between the
ability of AdipoR1 and AdipoR2 to contribute to osmotin-induced
Snf1p phosphorylation in S. cervisiae (Figure 7) and C2C12
myocytes [29] can also be explained in another way. Osmotin
stimulates IZH2-dependent and IZH2-independent signaling in S.
cerevisiae [29] and therefore stimulates AdipoR-independent
pathways also. If we assume that an AdipoR-independent
pathway(s) specifically and strongly inhibits the AdipoR2 depen-
dent Snf1p phosphorylation, it will appear as though osmotin
signaling is connected to AdipoR1 not AdipoR2 in S. cerevisiae. If
osmotin fails to stimulate an AdipoR-independent pathway that
Figure 8. Osmotin signaling mediated by adiponectin recep-
tors induces suppression of gene expression via stress
responsive promoter elements. Cells (about 108/mL) of strain
BWG1-7a Dizh2::Kan_MX co-transformed with pSTRE-lacZ(LEU2) and
p426-GPD (Vec), p426-GPD-AdipoR1 (pAdipoR1) or p426-GPD-AdipoR2
(pAdipoR2) were treated with osmotin (4 mM) in YPD for 45 min at 30uC
and b-galactosidase activity was measured at the end of the treatment
period. The values represent the means 6 SE of two independent
experiments with 3 to 4 samples per experiment.
doi:10.1371/journal.pone.0065454.g008
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inhibits AMPKa phosphorylation in the mammalian cells, it would
appear as if both AdipoR1 and AdipoR2 contribute to osmotin
activated AMPKa phosphorylation in the mammalian cells. There
are possibly several other explanations for the discrepancy
between the ability of AdipoR1 and AdipoR2 to contribute to
osmotin-induced Snf1p phosphorylation in S. cerevisiae (Figure 7)
and C2C12 myocytes [29]. Clearly our cell signaling assays can be
improved when connections leading from ligand-AdipoRs to
Snf1p phosphorylation and STRE-lacZ expression in S. cerevisiae
are elucidated further.
Besides its use in the identification of new agonists of AdipoRs,
the S.cerevisiae system described herein has potential for substan-
tially increasing our understanding of ligand-AdipoR interactions
and the resultant downstream signaling. For example, the spilt
luciferase system can be used to screen a library of receptor
mutants to delineate residues important for AdipoR-APPL1
interaction and AdipoR-ligand interactions. It should also be
possible to identify residues of APPL1 that are necessary for
AdipoR-APPL1 interaction by a similar approach. By screening a
collection of S. cerevisiae mutants for inability to support the
AdipoR1-APPL1 interaction, proteins required to stabilize this
interaction can be discovered. Similarly, by transforming an
expression library of mammalian cDNAs into S. cerevisiae having
the CLuc-AdipoR/APPL1-NLuc constructs, it should be possible
to identify mammalian proteins involved in stabilization/destabi-
lization of the AdipoR-APPL1 complex. All of these studies will be
greatly facilitated by our observation that the AdipoR-APPL1
interaction can be scored in S. cerevisiae colonies on plates. The
basic understanding required to identify new pharmaceutically
valid targets and the identification of AdipoR ligands that can be
facilitated by our S. cerevisiae assay system should have considerable
value in discovery of therapeutic interventions for metabolic
disorders.
Supporting Information
Figure S1 The AdipoR1 ligands, adiponectin and osmo-
tin, induce increase in luciferase reporter activity. Cells
of strain BY4741carrying pESC-URA-CLuc-AdipoR1-APPL1-
NLuc were grown for 16 h at 30uC in selective minimal medium
at the indicated galactose concentrations, treated for 4 h at 30uC
with the indicated test compounds and then assayed for luciferase
activity. A representative image of relative luciferase activity with
the different test compounds is shown for cells grown on 1% and
1.5% galactose. Luciferase (Luc) activities represent the means 6
SD from three independent experiments with triplicate samples
Symbols: PBS, 1/8 X PBS; OSM, 6.4 mM osmotin; f-ADPN,
2.8 mM bacterially expressed full length adiponectin; g-ADPN,
2.4 mM bacterially expressed globular adiponectin; f-ADPN*,
1.3 mM bacterially expressed full length adiponectin from a
commercial source.
(TIF)
Figure S2 (A) Homology model of AdipoR1 embedded in
membrane structure in preparation for molecular dynamics
simulations. AdipoR1 is shown with orange color; DPPC
membranes are shown with cyan color while water molecules
are shown with O-red color and H-white color. (B) RMSD vs time
after 50 ns of MD simulation at 300 K. The red curve indicates
RMSD for Ca atoms and the black curve shows the RMSD for
backbone atoms.
(TIF)
Figure S3 3D models of proteins and protein complexes
used in this study. (A) Homology model of AdipoR1. Residues
355–374 are marked in yellow. These residues are not considered
in the homology model developed by [49]. (B) Homology 3D-
model of trimeric human globular adiponectin. The beta strands
are indicated by arrows. Bound Ca2+ ions are shown as yellow
spheres. (C) 3D-structure of osmotin (PDB id. 1PCV-chain A). (D)
3D model of the AdipoR1 binding site. Common residues of
AdipoR1 interacting with both, adiponectin and osmotin are
shown in blue. Residues interacting with adiponectin only are
shown in red. (E) 3D model of the AdipoR1/adiponectin complex.
(F) 3D model of AdipoR1/osmotin complex. (G) Superposition of
homology model of adiponectin (cyan) and crystal structure of
adiponectin trimer (PDB id: 4DOU; orange). The RMSD between
Ca atoms is 0.45 A˚. Close-up shows loops of adiponectin involved
with interaction with AdipoR1.
(TIF)
Figure S4 Representation of AdipoR1 residues that
interact with ligands used in this study. Interacting residues
of AdipoR1 in the top-scoring complexes with adiponectin
(ADPN), osmotin and the TLP peptides shown in Table 1 are
shown. Interacting residues that were predicted by our model are
shown in red font and interacting residues predicted by the model
of [49] are shown in green font. C-terminal residues of AdipoR1
not included into the models are shown in gray font. P1, P2 and P3
represent the interactions of AdipoR1 with adiponectin and
osmotin in the first, second and third top-scoring complexes.
(TIF)
Figure S5 Complete sequences of protein models used
in this study. Shown in gray font are residues of the deduced
amino acid sequences of all three proteins that were not used in
the model. These include the N-terminal signal sequence of all the
proteins, the intracellular N-terminal sequence of AdipoR1, the
collagen domain of adiponectin and the C-terminal vacuolar
targeting sequence of osmotin. Amino acids indicated by the red
font represent the residues of AdipoR1 that interact with either
adiponectin or osmotin, residues of adiponectin that interact with
AdipoR1 and residues of osmotin that interact with AdipoR1,
respectively. The OSMpep fragment (residues 157–165) is
underlined and shown in bold.
(TIF)
Figure S6 Comparison of the binding of osmotin and
OSMpep to AdipoR1. (A) Overlay of the three top scoring
OSMpep poses (Green = best, purple = second, orange = third). (B)
Overlay of the three top scoring OSMpep poses and osmotin (red).
(TIF)
Figure S7 Osmotin signaling mediated by adiponectin
receptors does not induce Snf1p phosphorylation in wild
type BWG1-7a cells. Cells (about 108/mL) of strain BWG1-7a
transformed with p426GPD (Vec), p426GPD-AdipoR1 (pAdipoR1)
or p426GPD-AdipoR2 (pAdipoR2) were treated with osmotin and
adiponectin at 30uC in YPD. Aliquots were withdrawn for viable
counts determination before the cell lysates were prepared for
analysis by10% SDS-PAGE. 100 mg total proteins were loaded per
lane. (A) Time dependent changes in Snf1p phosphorylation with
osmotin (0.5 mM) or adiponectin (0.5 mM). Shown are blots
probed first with phospho-AMPK(Thr-172) antibody, then
stripped and probed with actin antibody. (B,C) Osmotin and
adiponectin concentration dependent changes in Snf1p psho-
sphorylation. Treatment time was 30 min. Shown in the top
panels are blots probed first with phospho-AMPK(Thr-172)
antibody, then stripped and probed with actin antibody. Shown
in the middle panels are relative band intensities in the depicted
gels. ‘Relative band intensity’ was defined as the ratio of the
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intensity of phospho-Snf1p signal to actin signal for each lane
when the value of this ratio for the corresponding untreated Vec
sample was arbitrarily assigned the value 1.0. Shown in the bottom
panels are viable counts in each sample at the end of the
treatments. The experiments were performed twice with compa-
rable results and the results of one experiment are shown.
(TIF)
Figure S8 Time dependent increase in Snf1 phosphor-
ylation in izh2 mutant in response to osmotin or
adiponectin treatment. Cells (about 108/mL) of strain
BWG1-7a izh2D transformed with p426GPD (Vec), p426GPD-
AdipoR1 (pAdipoR1) or p426GPD-AdipoR2 (pAdipoR2) were
treated with osmotin (0.5 mM) or adiponectin (0.5 mM) at 30uC
in YPD for the indicated times. Shown are blots of total protein
extracts fractionated by 10% SDS-PAGE that were probed first
with phospho-AMPK(Thr-172) antibody, then stripped and
probed with actin antibody. 100 mg total proteins were loaded
per lane.
(TIF)
Figure S9 Luciferase reporter activity depends on the
expression level of receptor at a constant level of APPL1.
(A) RT-PCR analysis of AdipoR1 and APPL1 expression in total
RNA (2 mg) from cells of strain BY4741 carrying indicated
plasmids that were grown for 16 h at 30uC in selective minimal
medium containing 2% galactose. ACT1 expression is shown for
normalization. (B-D) Quantification of luciferase activity in
BY4741 cells carrying indicated plasmids. Cells were grown for
16 h at 30uC in selective minimal medium at the indicated
galactose concentrations. The final concentration of sugars in all
media was adjusted to 2% with raffinose. Shown is quantification
of luciferase activity. Inset is a representative image of the
microplate (showing from left, cells grown in 0, 0.25, 0.5, 1, 1.5,
and 2% galactose). (E) Adiponectin stimulates luciferase activity.
Cells of strain BY4741 carrying p425GPD-APPL1-NLuc and
either pESC-URA-CLuc-AdipoR1 or pESC-URA-CLuc-Adi-
poR2 were grown for 16 h at 30uC in selective minimal medium
at the indicated galactose concentrations, treated for 2 h at 30uC
with 1/8 X PBS (2) or full length bacterially expressed
adiponectin (+). Luciferase activity was then visualized by imaging.
(TIF)
Table S1 Primers used for construction of plasmids.
(DOCX)
Table S2 Primers used for gene expression analysis by
RT-PCR.
(DOCX)
Methods S1
(DOCX)
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